Metro South Internal Medicine is categorized under Health Services in Saint Louis, MO and active since 2010.
Metro South Internal Medicine was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Sam Hawatmeh at the company’s single location by writing to 1400 Lemay Ferry Road, Saint Louis, Missouri MO 63125 or by phoning (314) 631-2030. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Metro South Internal Medicine |
| Contact Person: | Sam Hawatmeh |
| Address: | 1400 Lemay Ferry Road, Saint Louis, Missouri 63125 |
| Phone Number: | (314) 631-2030 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 6211110 |
| Share This Business: |
Metro South Internal Medicine was started in 2010 to provide professional Health Services under the SIC code 8099 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Sam Hawatmeh for inquiries that concern Metro South Internal Medicine by calling the company number (314) 631-2030, as your correspondence is most welcome. Additionally, the physical location of the single location of Metro South Internal Medicine can be found at the coordinates 38.53079,-90.28965 as well as the street address 1400 Lemay Ferry Road in Saint Louis, Missouri 63125.
For its online presence, you may visit Metro South Internal Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.